Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN104945299A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104945299A offers improved Vildagliptin synthesis. Homogeneous phase reaction enhances purity and simplifies supply chain for pharmaceutical intermediates.